Bosnia and Herzegovina - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes

Since 2014, Bosnia and Herzegovina Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes increased 3.5% year on year. In 2019, the country was number 33 comparing other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes with €42.73 Per Capita. Switzerland ranked the highest with €666.37 Per Capita in 2019, that is a growth of 3.2% versus 2018. Germany, Liechtenstein and Ireland respectively ranked number 2, 3 and 4 in this ranking. Latvia recorded the best 5 years average growth at +8.8% per year, while Romania recorded the worst performance at -1.7% per year.

Loading...

Date Euros Per Capita
2019 42.73
2018 42.11
2017 42.39
2016 42.80
2015 39.55
Download all data from 2013 to 2019

How does Bosnia and Herzegovina rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes?

# 33 Countries Euros Per Capita Last YoY 5‑years CAGR
1 #1
Switzerland
666.37 2019 +3.1 % +5.3 % View data
2 #2
Germany
553.39 2019 +2.3 % +3.0 % View data
32 #32
Cyprus
50.16 2019 -3.4 % +1.4 % View data
33 #33
Bosnia and Herzegovina
42.73 2019 +1.5 % +3.5 % View data
Compare all 33 countries

Go Top